Calyxt identifies more than 15,000 unique chemical signatures in lab-scale BioFactory production run
In Minnesota, Calyxt, Inc., a plant-based synthetic biotechnology company, completed a key milestone in its lab-scale BioFactory manufacturing system with results through the Company’s metabolomics analyses indicating over 15,000 chemical signatures, including both known and as-yet-uncharacterized molecules and building block precursors, chemical compounds involved in chemical reactions that produce other compounds. These chemical signatures form […]














